Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme

Overview of attention for article published in Clinical Drug Investigation, January 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 50 Dimensions

Readers on

mendeley: 186 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 47,774 followers.

RT @DNDi: Study confirms SSG&PM should be first-line treatment for visceral #leishmaniasis in Eastern Africa https://t.co/HgJYSfG6GD #spri…

22 Jan 2017

Reply Repost Favourite

RT @DNDi: Study confirms SSG&PM should be first-line treatment for visceral #leishmaniasis in Eastern Africa https://t.co/HgJYSfG6GD #spri…

22 Jan 2017

Reply Repost Favourite

RT @Mottram_group: Sad state of affairs that SSG still has to be used for treatment of VL in East Africa - new drugs desperately needed for…

12 Jan 2017

Reply Repost Favourite

RT @DNDi: Study confirms SSG&PM should be first-line treatment for visceral #leishmaniasis in Eastern Africa https://t.co/HgJYSfG6GD #spri…

11 Jan 2017

Reply Repost Favourite

Sad state of affairs that SSG still has to be used for treatment of VL in East Africa - new drugs desperately needed for #leishmaniasis https://t.co/Km6rXYILRm

11 Jan 2017

Reply Repost Favourite

Study confirms SSG&PM should be first-line treatment for visceral #leishmaniasis in Eastern Africa https://t.co/HgJYSfG6GD #springerlink

11 Jan 2017

Reply Repost Favourite